期刊文献+

肿瘤主动靶向磁性纳米粒子研究现状及其在肿瘤热疗中的应用 被引量:6

Active Targeting Magnetic Iron Oxide Nanoparticles:Current Status and Novel Applications in Tumor Hyperthermia
原文传递
导出
摘要 磁性纳米粒子已广泛应用于肿瘤的成像和治疗,但限制其临床应用的重大障碍是纳米粒子在肿瘤部位不能达到足够的浓度。主动靶向磁性纳米粒子是磁性纳米粒子表面偶联特定的靶向配体,靶向性结合特定的肿瘤细胞。靶向配体的选择是提高主动靶向性的关键。主动靶向性提高了磁性纳米粒子在肿瘤组织内的浓度,减少对正常组织的毒性,从而使其在肿瘤成像与治疗成为可能。磁感应热疗利用磁介质在外加交变磁场的作用下感应发热,是一种新型的具有前景的肿瘤治疗手段。依靠磁性纳米粒子主动靶向性,磁感应热疗将更好地实现细胞内热疗,提高肿瘤治疗的疗效。 Magnetic nanoparticles are important tools in tumor imaging and therapy.However,low therapeutic concentration of the nanoparticles at the tumor sites has limited their clinical applications.Active targeting employs magnetic nanoparticles conjugated to specific ligands that selectively bind to biomarkers on target cells.Several receptor systems are overexpressed in cancerous diseases and have been investigated as targets for ligand-directed magnetic nanoparticles.The target receptors undergo repeated recycling between the cell surface and internalization,and bind to magnetic nanoparticles,thereby amplifying the magnetic signal for more precise diagnosis and treatment.This paper summarizes the recent advances in the development of active targeted magnetic iron oxide nanoparticles for tumor imaging and therapy.Magnetic nanoparticles with an alternating magnetic field can convert electromagnetic energy into heat and confine the heat to the tumor tissue.Magnetic fluid hyperthermia is a promising approach to cancer therapy because it not only directly kills cancer cells,but also indirectly activates anticancer immunity.Modifying the surface of magnetic nanoparticles to target specific molecules could improve their intracellular accumulation and their ability to target on tumor cells,and thus enhance their hyperthermia effects.
出处 《科技导报》 CAS CSCD 北大核心 2010年第19期108-112,共5页 Science & Technology Review
基金 国家高技术研究发展计划(863计划)项目(2007AA021805)
关键词 肿瘤 磁性纳米粒子 主动靶向 磁感应热疗 tumor magnetic iron oxide nanoparticles active targeting magnetic inductive hyperthemia
  • 相关文献

参考文献4

二级参考文献60

  • 1XlAO Suyao TONG Chunyi LIU Xuanming YU Danmi LIU Qiaoling XUE Changgang TANG Dongyin ZHAO Lijian.Preparation of folate-conjugated starch nanoparticles and its application to tumor-targeted drug delivery vector[J].Chinese Science Bulletin,2006,51(14):1693-1697. 被引量:13
  • 2Gillies RJ, Bhujwalla ZM, Evelhoch J, Garwood M, Neeman M, Robinson SP, Sotak CH, van Der SB. Applications of magnetic resonance in model systems:tumor biology and physiology.Neoplasia, 2000,2:139-151.
  • 3Pautler RG. Mouse MRI: concepts and applications in physiology. Physiol, 2004,19:168-175.
  • 4Homak JP. The basics of MRI. http://www.cis.rit, edu/people/faculty/homak/.
  • 5Persigehl T, Heindel W, Bremer C. MR and optical approaches to molecular imaging. Abdom Imaging, 2005,30: 342-354.
  • 6Artemov D. Molecular magnetic resonance imaging with targeted contrast agent. J Cell Biochem, 2003,90:518-524.
  • 7Massoud YF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Gene Dev, 2003,17:545-580.
  • 8Blasberg RG. Molecular imaging and cancer.Mol Cancer Ther, 2003,2:335-345.
  • 9Nobs L, Buchegger F, Gumy R, Allemann E. Current methods for attaching targeting 1Ligands to liposomes and nanoparticles. J Pharm Sci, 2004,93:1980-1992.
  • 10Keer HN, Kozlowski JM, Tsai YC, Lee C, McEwan RN, Grayhack JT. Elevated transferrin receptor content in human prostate cancer cell lines assessed in vitro and in vivo. J Urol, 1990,143:381-385.

共引文献11

同被引文献65

  • 1杨春娥,石小鹏.单克隆抗体类抗肿瘤药物的临床应用和进展[J].中国新药与临床杂志,2005,24(2):136-139. 被引量:7
  • 2魏黎,雷皓.以超顺磁氧化铁微粒为探针的磁共振影像技术[J].生物物理学报,2009,0(S1):62-63. 被引量:1
  • 3Jingchang ZHANG,Qing LI,Weiliang CAO.Preparation of (Ti, Sn)O_(2) Nano-Composite Photocatalyst by Supercritical Fluid Dry Combination Technology[J].Journal of Materials Science & Technology,2005,21(2):191-195. 被引量:1
  • 4张阳德.纳米药物学[M].北京.化学工业出版社.2005.10
  • 5Allen TM, Cullis PR. Drug delivery systems: entering the main- stream [J].Science, 2004, 303(5665):1818-1822.
  • 6Maeda H, Bharate GY, Daruwalla J. Polymeric drugs for efficient tumor-targeted drug delivery based on EPR--effect[J]. EurJ Pharm Biopharm, 2009, 71 (3) :409-419.
  • 7Moghimi SM, Hunter AC, Murray JC. Long-circulating and tar- get-specific nanoparticles: theory to practice[J]. Pharmacol Rev, 2001, 53(2):283-318.
  • 8Danhier F, Lecouturier N, Vroman B, et al. Paclitaxel-loaded PE- Gylated PLGA-based nanoparticles: in vitro and in vivo evaluation [J]. J Control Release, 2009, 133 (1) :11-17.
  • 9Lu Y, Low PS. Folate--mediated delivery of macromolecular anticancer therapeutic agents[J]. Adv Drug Deliv Rev, 2002, 54(5):675-693.
  • 10Shen Z, Li Y, Kohama K, et al. Improved drug targeting of cancer cells by utilizing actively targetable folic acid-conjugated albumin- nanospheres[J].Pharmacol Res, 2011, 63 (1):51-58.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部